Trials / Completed
CompletedNCT04843748
Clinical Evaluation Study for Assessing the Visual Performance of Hanita Lenses Trifocal IOL
Clinical Study for Assessing the Visual Performance of Hanita Lenses New Trifocal Intraocular Lens
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Hanita Lenses · Industry
- Sex
- All
- Age
- 45 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Hanita Lenses Trifocal IOL, SeeLens AFR (Intensity IOL).Prospective, single-arm single-center, open-label study.
Detailed description
Device: Hanita Lenses Trifocal IOL, SeeLens AFR (Intensity IOL). Indication studied: The Hanita Lenses Trifocal IOL is intended for implantation in the capsular bag in the posterior chamber in order to replace the crystalline lens of the eye to attain visual correction of aphakia in adult patients in whom a cataractous lens has been removed, who desire improved uncorrected vision, useful near and intermediate visual functions, and reduced spectacle dependence. Study description: This study is a prospective, single-arm single-center, open-label study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | cataract surgery and intraocular lens implantation - both eyes | cataract surgery and intraocular lens implantation for both eyes |
Timeline
- Start date
- 2018-08-18
- Primary completion
- 2021-01-06
- Completion
- 2021-01-06
- First posted
- 2021-04-14
- Last updated
- 2021-04-14
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT04843748. Inclusion in this directory is not an endorsement.